| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.44B | -9.4% |
| Cost of Revenue | $1.12B | -19.0% |
| Gross Profit | $4.32B | -6.6% |
| R&D Expense | $1.05B | -1.8% |
| SG&A Expense | $1.79B | -1.9% |
| Operating Income | $1.38B | -10.1% |
| Pre-tax Income | $1.55B | -3.1% |
| Income Tax | $152.1M | -23.5% |
| Net Income | $4.17B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.05B | +166.2% |
| Short-term Investments | $930.7M | +86.0% |
| Accounts Receivable | $609.1M | -21.4% |
| Inventory | $1.09B | -7.0% |
| Current Assets | $6.29B | +55.7% |
| Total Assets | $13.06B | +39.4% |
| Current Liabilities | $1.51B | +25.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $542.3M | -39.5% |
| Capital Expenditures | $252.4M | -0.2% |
| Investing Cash Flow | $2.31B | +1230.8% |
| Financing Cash Flow | -$983.0M | -38.3% |
| Free Cash Flow | $289.9M | -54.9% |
| +197.7% |
| EPS (Basic) | $6.98 | +202.2% |
| EPS (Diluted) | $6.97 | +203.0% |
| Long-term Debt |
| $597.7M |
| +0.1% |
| Total Liabilities | $2.99B | +13.2% |
| Stockholders' Equity | $10.00B | +50.4% |